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Abstract— Neurosurgery targets in the thalamus can be 
challenging to identify during transcranial MRI-guided 
focused ultrasound (MRgFUS) thermal ablation due to poor 
image quality. They also neighbor structures that can result 
in side effects if damaged. Here we demonstrate that the 
phase data obtained during MRgFUS for MR temperature 
imaging (MRTI) contains anatomic information that could 
be useful in guiding this procedure. This approach was 
evaluated in 68 thalamotomies for essential tremor (ET). We 
found that we could readily visualize the red nucleus and 
subthalamic nucleus, and those nuclei were consistently 
aligned with the sonication target coordinates. We also 
could consistently visualize the internal capsule, which 
needs to be protected from thermal damage to prevent side 
effects. Preliminary results from four pallidotomies in 
Parkinson’s disease patients suggest that this approach 
might also be useful in visualizing the optic tract in addition 
to the internal capsule. Overall, this approach can visualize 
anatomic landmarks that may be useful to refine atlas-
based targeting for MRgFUS. Since the same data is used 
for MRTI and anatomic visualization, there are no errors 
induced by registration to previously obtained planning 
images or image distortion, and no additional time is 
needed. 
 
Index Terms—Essential Tremor, Focused ultrasound, 
Magnetic Resonance Imaging, Neurosurgery, Parkinson’s 
disease, Thermometry  
I. INTRODUCTION 
HALAMOTOMY with transcranial MRI-guided focused 
ultrasound (MRgFUS) thermal ablation is a noninvasive 
surgical approach that is approved for the treatment of essential 
tremor (ET) and tremor-dominant Parkinson’s disease (PD)  [2, 
3]. MRgFUS thalamotomy for neuropathic pain, pallidotomy 
for PD, and capsulotomy for obsessive compulsive disorder, 
and other indications are also being investigated [5-7]. 
Effectively treating these disorders without invasive surgery or 
ionizing radiation is a desirable option for many patients 
compared to deep brain stimulation, radiofrequency lesioning, 
or gamma knife radiosurgery. 
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Currently, the target for thalamotomy is selected based upon 
human stereotactic atlases and by measurements relative to 
anatomic structures such as the anterior commissure (AC), the 
posterior commissure (PC), and wall of the third ventricle. The 
target is typically selected on MRI scans acquired with the body 
coil with the patient in the MRgFUS device. The device itself 
and the water used to cool the head and provide acoustic 
coupling interfere with imaging leading to poor image quality. 
As a result, relevant anatomic structures in and around the 
thalamus are not well visualized. 
Knowing the locations of these structures is also important to 
avoid side effects. The MRgFUS focal lesion is often oblique 
[8] and heating can extend into neighboring structures such as 
the internal capsule (IC). Improved anatomic imaging could 
also be useful in refining the sonication target, as atlas-based 
measurements alone do not take into account individual 
variability. Atlas-based planning can be enhanced using 
previously obtained high resolution imaging that is registered 
to the treatment planning images.  Such imaging can allow for 
better visualization of relevant anatomy, but targeting based on 
it is only as good as the registration accuracy and can be 
susceptible to image distortion. While sub-millimeter 
registration error can be achieved under ideal conditions [9], the 
accuracy of the registration with the poor-quality images 
currently used with MRgFUS is not known.  Furthermore, the 
requirement of a pre-treatment MRI for planning purposes is an 
added expense. Methods to refine both atlas-based targeting and 
direct targeting based on pre-treatment imaging would be 
beneficial. 
The accuracy of the targeting and the accumulated thermal 
dose [10] during MRgFUS are monitored using MR 
temperature imaging (MRTI). This imaging is based on the 
temperature sensitivity of the proton resonant frequency of 
water [11]. Changes in resonant frequency are estimated using 
phase-difference images created with a gradient echo pulse 
sequence [12]. MRTI is obtained at multiple time points to track 
the heating during each sonication. 
The phase of an MR image also contains anatomic 
information [13]. Structures such as the red nucleus (RN), 
substantia nigra (SN), and the subthalamic nucleus (STN), 
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contain higher concentrations of iron [14]. This iron in the 
tissue consists largely of ferritin and hemosiderin and is 
paramagnetic. The magnetic field thus becomes slightly 
increased in these structures, which leads to a more phase 
accumulation between excitation and readout of the MRI data. 
The phospholipids in heavily myelinated white matter are 
diamagnetic, leading to decreased phase accumulation. These 
anatomic structures can be readily visualized by unwrapping 
the phase maps and removing contributions caused by 
inhomogeneities in the static magnetic field. These 
inhomogeneities have low spatial frequencies and can be 
removed with a high-pass filter [15, 16]. 
For tremor, the lesion is placed in the posteroventral portion 
of the ventralis intermedius (VIM) nucleus in the thalamus. 
This target is approximately aligned anteroposteriorly with the 
RN [1]. The VIM is adjacent to the internal capsule (IC) 
laterally and the zona incerta (ZI) inferiorly. The STN lies just 
below the ZI. Visualization of the RN, IC, and STN could thus 
be useful as landmarks to improve atlas-based targeting of the 
VIM and avoid damage to the IC.   
In this work we show that the phase images acquired during 
sonication that are used for temperature mapping can reliably 
visualize these structures during thalamotomy for tremor. We 
retrospectively evaluated the imaging acquired during and after 
68 MRgFUS thalamotomies and compared the average 
locations of these structures to the targets, the MRI-derived 
thermal dose, and the lesion at 24 h. We show that the locations 
of the nuclei in the phase maps are at locations expected from a 
stereotactic atlas, suggesting that these images could be useful 
to refine atlas-based targeting and avoiding damage to the IC. 
We also show preliminary results from four MRgFUS 
pallidotomies, where in addition to the IC, the optic tract ventral 
to the sonication target was detected. 
II. METHODS 
A. MRgFUS 
We analyzed data from 68 MRgFUS procedures for ET and 
four for PD. For ET thalamotomy, the sonication target in the 
VIM nucleus. The nominal location of the target was 14 mm 
lateral to the midline, 25% of the ACPC distance anterior to the 
PC, and 1 mm superior to the ACPC plane. The neurosurgeon 
adjusted these coordinates based on the width of the third 
ventricle, the cranial size, and other considerations. For PD 
pallidotomy, the target was the globus pallidus interna (GPi), 
with a nominal location of 20 mm lateral to the midline, 3-4 mm 
anterior to the midpoint between AC and PC, and 3-4 mm 
inferior to the ACPC plane. The neurosurgeon adjusted those 
targets based on pre-treatment imaging and patient anatomy. 
The targeting is refined during treatment based on symptom 
improvement and reported side effects. 
The treatments were performed using the ExAblate Neuro 
MRgFUS system (InSightec, Haifa, Israel). This system uses a 
hemispherical (diameter: 30 cm), 1024-element phased array 
transducer that operates at 660 kHz. The transducer was 
integrated into an MRI table for a 3T MRI (GE750W, GE 
Healthcare). The transducer was steered to within ±1 mm of the 
target selected by the neurosurgeon with a manual positioning 
system. Additional steering was provided by the phased array. 
The array was also used to correct for aberrations induced by 
the skull. This correction used information gleaned from CT 
scans obtained before treatment to predict and reverse skull-
induced phase changes for each element [17]. The power for 
each element was set to normalize the intensity over the skull 
surface. The location and orientation of the transducer in the 
MRI space was obtained using MRI tracking coils. 
Before treatment, the patient’s head was completely shaved, 
and they were placed in a stereotactic frame. A flexible 
waterproof membrane was stretched around the head. The 
patient was laid supine and the frame was attached securely to 
the MRI table. The membrane was attached to the open face of 
the MRgFUS transducer. The space between the scalp and 
transducer was filled with degassed and cooled water that was 
continuously circulated between sonications.  
B. MRI acquisition for temperature imaging 
The targeting was verified using low energy (typically 1-3 
kJ) sonications and MRTI. At least three verification 
sonications were applied to confirm targeting in each direction. 
Because of spatial distortions in the frequency-encoding 
direction, the verification only considered coordinates in the 
phase-encoding direction. After verification, the acoustic 
energy was increased to ablative levels in steps. Between each 
ablation sonication, the patient was withdrawn from the scanner 
and examined for symptom improvement and side effects. 
Based on these examinations, the sonication target was adjusted 
 
Fig. 1 Processing phase data obtained during sonication in two ways. 
(a) For MRTI, the phase maps acquired before heating are subtracted 
from those obtained at multiple time points during and after sonication. 
(b) To create the filtered phase maps, we first averaged all the phase 
maps acquired at all time points to increase the SNR. Anatomic 
information is faintly visible in the unwrapped phase map. A low pass 
filter of this data is created and then subtracted, and the resulting 
filtered phase map shows structural information with high contrast in 
the striatum and thalamus. Phase changes in the focal regions due to 
focal heating were not fully removed. Note that the heat-induced phase 
change in this example (focal temperature rise: 29.4°C) was larger than 
those associated with anatomic differences in magnetic susceptibility. 
Axial imaging is shown. 
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if necessary. Sonications were repeated until symptoms were 
substantially improved. Exposure levels were determined using 
MRTI, with an aim of achieving focal temperatures of ~51-
60°C. Information about the sonication targeting and patient 
information is shown in Table S1. 
Imaging for MRTI was obtained in a single plane using a 
spoiled gradient echo sequence. The orientation and frequency 
encoding direction of the MRTI was varied between 
sonications. For 17 treatments, a single echo readout was used 
(TR/TE: 27.8/12.9 ms; flip angle: 30°; receiver bandwidth ±5.7 
kHz; field of view: 28 cm; slice thickness: 3 mm; matrix: 
256×128). Otherwise the imaging was obtained using a multi-
echo readout (TR: 28.0 ms; TE: 3.1/7.8/12.5/17.2/21.9 ms; flip 
angle: 30°; receiver bandwidth: ±35.71 kHz; field of view: 28 
cm; slice thickness: 3 mm; matrix: 256×128). The low 
bandwidth of the single-echo imaging resulted in obvious 
distortions, often a millimeter or more, in the frequency 
encoding direction (Supplemental video 1). 
Phase difference maps were generated with reference to 
imaging obtained before the start of sonication (Fig. 1a); 
imaging was repeated at multiple time points during heating and 
for five frames afterwards. Temporal changes in the phase 
difference maps unrelated to heating were removed by fitting 
non-heated areas to a smooth surface using a procedure outlined 
previously [18, 19]. With the multi-echo readout, we computed 
phase difference maps with respect to a pre-heating image for 
each TE and combined them using a weighted average with 
weights for the nth TE given by: 
𝑊௡ = ቀ𝑇𝐸௡ ∙ 𝑒ି
்ா೙ ்ଶ∗ൗ ቁ
ଶ
 (1)
We used 30 ms for the 𝑇2∗ relaxation time for brain. 
The data were reconstructed as magnitude, real, and 
imaginary images in DICOM format. MRTI was generated 
using a temperature sensitivity -0.00909 ppm/°C [20], which 
was the value used by the MRgFUS software. The time series 
of MRTI was used to create maps of thermal dose [10].  
The same data obtained for MRTI was used to create the 
filtered phase maps (Fig. 1b). First, we averaged all the complex 
images acquired during and after each sonication. After 
masking the images with segmentations of the brain, the phase 
was then unwrapped using a technique described elsewhere 
[21]. The segmentations were performed on the magnitude 
reconstructions of the MRTI. We removed the low spatial 
frequency components of the phase maps resulting from static 
magnetic field inhomogeneities, which we found using an 
averaging filter in the spatial domain with a kernel size of nine 
voxels (9.8 mm) [22]. With this filter, each voxel was averaged 
with its 80 neighbors in 9×9 voxel grid. This low pass filtered 
phase map was subtracted off, leaving only the high spatial 
frequency components that contained anatomic information. 
For the multi-echo images, filtered phase maps for each TE 
were created separately and then combined using a weighted 
average with weights given by eq. 1. 
The imaging plane used for MRTI was aligned with the MRI 
bore, not the ACPC plane (Fig. S1). The mean rotation about 
the lateromedial axis with respect to the ACPC plane was 4.8 ± 
4.7°. The rotations about the dorsoventral and anteroposterior 
axes were 1.2 ± 2.1° and 0.6 ± 2.6°, respectfully. 
C. Segmentation 
For each treatment, we segmented the RN in axial phase 
images and the STN and the RN in coronal phase images. For 
this segmentation, we selected the first sonications in each 
treatment in the different imaging orientations, and when 
available, for different frequency-encoding directions. The 
coordinates of the centroids of these segmentations were 
recorded. In addition, we segmented the internal capsule in both 
axial and coronal images. Finally, we segmented the central 
hyperintense region of the lesion in T2-weighted imaging 
obtained 24 h after treatment. When coronal T2-weighted 
images were not acquired at 24 h, we segmented the 
hypointense areas in T1-weighted images. These segmentations 
were performed on axial and coronal images interpolated to the 
planes used for MRTI after registration to the treatment 
 
Fig. 2 Anatomic structures visible on the phase maps, along with 
thermal dose contours. The segmentations of the IC, RN, and STN are 
indicated. The lateroventral portion of the IC was often not visible in 
coronal imaging (*), perhaps due to its orientation at the “magic angle”
[4] of 54.74° with respect to the magnetic field (dotted green line). The 
RN was separated into dorsal and ventral components. (CN: caudate 
nucleus; EC: external capsule; GP: globus pallidus; IC: internal 
capsule; RN: red nucleus; SN: substantia nigra; STN: subthalamic 
nucleus). 
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planning images described below. We also recorded the 
locations of the sonication targets selected by the neurosurgeon 
and the centroid of the accumulated thermal dose. In the ACPC 
plane we recorded the left/right coordinate of the third ventricle.  
D. Image registration 
Treatment planning MRI used a 3D FIESTA sequence for ET 
patients, and either the FIESTA sequence or T2-weighted 
imaging in PD patients. Axial and coronal T2-weighted MRI 
was obtained 24 hours after treatment with a fast spin echo 
sequence with a slice thickness of 2 mm in every patient. These 
images were manually registered to the treatment planning 
images using 3D Slicer (www.slicer.org). When coronal T2-
weighted images were not available, we used 3D T1-weighted 
images. We interpolated the axial and coronal planning images 
and the imaging obtained 24 hours after treatment to the 
imaging planes used for MRTI in MATLAB. To correct for 
minor residual errors after the manual 3D registration, we 
applied additional 2D registration between the interpolated 
planning and post-treatment imaging using the “imregtform.m” 
function in MATLAB.  
E. Accumulated thermal dose 
The total thermal dose at the sonication target accumulated 
over multiple sonications at different targets and exposure 
levels. The MRTI imaging plane varied between sonications, so 
we could not directly compare the total accumulated thermal 
dose to the post-treatment imaging. To estimate the 
accumulated dose, we created temperature map templates for 
the imaging orientations used during each treatment.  
To create the templates, we first fit the heating and cooling 
trajectories of the hottest voxel to exponential functions: 
Δ𝑇𝑓𝑖𝑡ሺ𝑡ሻ = ሺ𝑎1 − 𝑒−𝑎2𝑡ሻ𝑒−𝑎3𝑡  (heating) 
Δ𝑇𝑓𝑖𝑡ሺ𝑡ሻ = 𝑏1𝑒−𝑏2ሺ𝑡−𝑡𝑑ሻ     (cooling) 
The 𝑎୬ and 𝑏௡ coefficients were determined using the 
“nlinfit.m” function in MATLAB with robust options. If the 
time of the MRTI acquisition was within 1 s of the sonication 
duration (𝑡ௗ), it was included in the heating curve fit even if it 
exceeded the sonication duration. The same rule was applied to 
the cooling. When extrapolated to the time of the heating 
duration, the fit heating and cooling curves often gave slightly 
 
Fig. 3 Axial phase maps acquired during sonication (left) and corresponding T2-weighted images acquired 24 h later (right) for six treatments in 
ET patients. The T2-weighted images were registered to the treatment images. The segmentations and accumulated thermal dose contours
superimposed on the T2-weighted images were all generated from the image data obtained during sonication. Dose contours were created 
separately for LR and AP frequency-encode directions in MRTI. The locations of the AC and PC are also shown. 
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different values. We scaled both curves by the average of the 
two curves at this time and re-normalized them. For each 
sonication, we fit ten time points to the heating and ten to the 
cooling.  
We next interpolated the MRTI spatially to a grid size of one 
fifth the native voxel dimensions and temporally to the same 
vector used in the exponential fits (ten time points during 
heating, ten during cooling). We then divided the MRTI by the 
maximum heating at the focus and multiplied them by 
Δ𝑇𝑓𝑖𝑡ሺ𝑡ሻ maxൣΔ𝑇𝑓𝑖𝑡ሺ𝑡ሻ൧⁄ . For each imaging orientation, we 
performed a weighted average of these normalized data with 
weights determined by the peak temperature rise squared. We 
only included sonications where the peak temperature rise was 
greater than 7°C, and we created separate templates for 
different frequency-encoding directions.  
We estimated the accumulated thermal dose in the axial and 
coronal planes used in MRTI in the first sonications of each 
treatment. To include sonications with different orientations, 
we fit the temperature rise as a function of time for the hottest 
voxel to exponential functions as described above and then 
multiplied it by the template to create simulated MRTI. If the 
focus was steered to a different coordinate within the plane of 
the template, we used interpolation to translate the template. 
When it was out of plane, we multiplied by a derating factor 
obtained from the spatial profile of the heating in the MRTI 
templates of that treatment.  
The estimated accumulated thermal dose maps were used 
here to compare the location of the MRTI-estimated thermal 
dosimetry to anatomic structures in the filtered phase maps. 
Further details on the agreement of the accumulated thermal 
dose maps with the resulting lesions in MRI will be presented 
in a future report. Throughout this paper, thermal dose contours 
indicate 18 equivalent minutes at 43°C, a value previously 
found to be the threshold for thermal brain damage in rabbits 
[23].  
F. Data analysis 
The main goal of this work was to determine the consistency 
of the detectability and the locations of identifiable anatomic 
structures in the phase mapping. This analysis was done 
primarily by manual inspection of the segmented structures and 
the registered post-treatment MRI. To further this goal, we 
combined the results of all treatments. The coordinates of the 
voxels within the segmentations of the RN, STN, and IC along 
with those within the accumulated thermal dose contours were 
rotated to a common reference frame so that the PC was located 
at the origin and the ACPC line was oriented along the 
anteroposterior direction. For visualization, this information 
was used to generate maps of the probability for each voxel to 
be within a segmentation of the RN, STN, or IC, or within the 
accumulated thermal dose contour. The coordinates of the 
targets, the lesions at 24 h, the centroids of the thermal dose 
 
Fig. 4 Coronal phase maps acquired during sonication and corresponding T2-weighted images acquired 24 h later for six thalamotomies in ET
patients. The T2-weighted images were registered to the treatment images. The segmentations and accumulated thermal dose contours
superimposed on the T2-weighted images were all generated from the image data obtained during sonication. Dose contours were created
separately for LR and SI frequency-encode directions in MRTI.The ACPC planes are also shown. 
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contours, and the centroids of the RN and STN segmentations 
were compared using paired t-tests. A value of P<0.05 was 
considered statistically significant. 
III. RESULTS 
G. ET treatments 
Fig. 2 shows representative examples of axial and coronal 
phase maps from ET patients annotated with different anatomic 
structures. Segmentations of the IC and the RN are 
superimposed along with contours of the accumulated thermal 
dose delivered over the respective treatments. In coronal 
imaging, the RN was split into a dorsal and ventral component 
as described elsewhere [24]. In coronal imaging, the STN is 
also segmented. 
Fig. 3 shows examples of axial phase maps and the 
corresponding T2-weighted imaging acquired 24 h after 
treatment after registration for six patients. The locations of the 
 
 
Fig. 5 (a)  Target locations shown with respect to anatomic structures and thermal dose contours obtained with the phase maps. The images show the 
probability each point being within either a thermal dose contour or a segmentation of the RN, IC, or STN. The centroids of these segmentations (circles) 
along with the target coordinates (x) are also shown. The contours indicate regions where the probability for being within a segmentation or isodose line 
was 50%. The lesion contour (dashed line) indicates the 50% probability of being within the lesion segmentation in MRI obtained at 24 h. The maps were 
created after aligning the ACPC planes. (b) The contours from (a) superimposed on panels from the Morel atlas of the thalamus [1]. In the ACPC plane 
(DV0), the positions of the IC and the atlas-based target (red x) agreed on average. The RN is evident in an axial panel 2.7 mm ventral to the ACPC
plane (V2.7) and aligned in the posteroanterior direction with the atlas target. In a coronal panel 7 mm anterior to the PC (A7), the locations of the STN 
in the atlas and in the phase maps overlapped, and the lateral positions of the RN were consistent. Overall, the targets were consistently positioned with 
respect to the RN in the AP direction, the STN in the LR direction, and ACPC plane and RN in the SI direction. 
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RN, STN, and the IC and along with the thermal dose contours 
were all generated from the phase data used to create the MRTI. 
The IC was observed in all (68/68) treatments in axial imaging. 
The RN was detected in 96% (65/68) of the treatments in axial 
imaging. It was not seen in two treatments where the sonication 
target was localized superior to the RN. In another, artifacts 
caused by a previous DBS electrode obscured the RN.  
Coronal examples for six patients are shown in Fig. 4. The 
IC was clearly observed in every patient. However, 
lateroventral portions of the IC (* in Fig. 2) were often not 
visible in coronal imaging, but they could be inferred by 
extrapolation. The STN was visualized in 96% (65/68) of the 
treatments; when it was not detected it was confounded by 
phase changes induced by heating. In some cases, heat-induced 
phase changes also overlapped with the IC, making 
discrimination between the two challenging.  
Filtered phase images, and corresponding imaging acquired 
at 24 h after MRgFUS for all patients are included in the 
Supplemental Data. Inspection of these data demonstrate the 
consistent delineation of the IC, RN, and in coronal imaging, 
the STN. Sagittal imaging was less revealing, but often showed 
the anteroposterior trajectory of the STN (Fig. S2).  
The IC, RN and STN were segmented in the coronal and 
axial phase imaging for 68 ET patients. The coordinates of the 
voxels contained within the segmentations along with those of 
the accumulated thermal dose isocontours were rotated to a 
common reference frame defined by the AC, the PC, and the 
midline. We used this information to visualize the average 
anatomic, dosimetry, and targeting information for the 68 
patients. This analysis is summarized in Fig. 5, where the color 
map shows the relative probability of each point in the coronal 
and axial images of being within the segmentations or isodose 
contours. The locations of the centroids of these regions and the 
sonication targets are also shown. For coronal imaging, we used 
the dorsal portion of the RN. Taken together, the targets and the 
thermal dose contour centroids were aligned with the RN 
anteroposteriorly. The targets were approximately 1 mm lateral 
to the STN lateromedially, 2 mm dorsal to the RN in coronal 
imaging. We also superimposed the 50% contour for the lesions 
segmented from imaging at 24 h after treatment. 
 Table 1 shows the distance between landmarks identified in 
the treatment planning imaging (AC, PC, midline, ventricle 
wall) and post-treatment imaging (lesion) to those obtained 
from phase mapping obtained during sonication (the centroids 
of the RN/STN, accumulated thermal dose contours). As 
expected, the targets and isodose centroids were, on average, 
close to the nominal atlas-based coordinates of 11 mm lateral to 
the ventricle wall, anterior to the PC at 25% of the ACPC 
distance, and 1 mm dorsal to the ACPC plane. The variability 
in these coordinates – a standard deviation of approximately ±1 
TABLE I 
MEAN DISTANCES BETWEEN THE TARGETS AND THE CENTROIDS OF THE 
LESIONS, DOSE CONTOURS, AND ANATOMIC STRUCTURES 
Lateromedial (coronal) mean ± stdev. Pa N
Midline to target (mm) 14.5 ± 1.0 - 68
Ventricle to target (mm) 10.4 ± 0.9 - 68
Ventricle to isodose (mm) 10.7 ± 1.2 0.189 67
Ventricle to lesion (mm) 10.2 ± 1.5 0.188 68
Ventricle to STN (mm) 9.6 ± 1.1 0.500 65
Posteroanterior (axial) mean ± stdev. Pa N
ACPC distance (mm) 26.3 ± 1.6 - 68
PC to target (%ACPC dist.) 25.3 ± 2.5 - 68
PC to target (mm) 6.7 ± 0.8 - 68
PC to isodose (mm) 6.8 ± 1.0 <0.001 67
PC to lesion (mm) 7.9 ± 0.7 <0.001 68
PC to RN (mm) 7.2 ± 1.0 0.954 65
Dorsoventral (coronal) mean ± stdev. Pa N
ACPC plane to target (mm) 1.1 ± 0.8 - 68
ACPC plane to isodose (mm) 1.0 ± 1.2 <0.001 68
ACPC plane to lesion (mm) 2.8 ± 1.1 <0.001 68
ACPC plane to RNb (mm) -0.7 ± 0.9 0.051 68
aCompared to target distance with paired t-tests; lateromedial STN
distance offset by 1 mm in the comparison; dorsoventral distance of
RN offset by 2 mm; bdorsal component. 
 
Fig. 6 Potential use of this approach to avoid damage to the IC. The 
upper image is a map of the maximum temperature rise during a 
relatively low-energy sonication. The thermal dose estimated for this 
sonication (red contour) predicted only a small lesion that did not 
include the IC (magenta contour). Estimating what might occur if the 
temperature rise was increased by a factor of two or three (turquoise, 
blue contours) indicates that higher-energy sonication would damage 
the IC. Without this knowledge of the IC location, subsequent 
sonications were performed at higher energy that resulted in a lesion 
that included the IC (lower image). The accumulated thermal dose from 
all the sonications in the treatment superimposed on this image agrees 
reasonably with the extrapolation of the low-energy sonication on the 
left and the lesion evident in MRI at 24 h after MRgFUS. 
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mm – was similar to that found for the centroids of the RN and 
STN. The differences between the centroids of the RN 
anteroposteriorly, the STN offset medially by 1 mm medially, 
and the RN offset 2 mm dorsally and the target coordinates were 
not statistically significant (P>0.05). 
Using both the anatomic and thermal information together 
could provide a way to extrapolate low energy sonications and 
assess the risk to the IC. An example of how this might be used 
is shown in Fig. 6, where a sonication obtained at a relatively 
low energy is scaled to predict the thermal dose at a higher 
energy [23]. In the patient shown in Fig. 6, without knowledge 
of the location of the IC, subsequent sonications at higher 
energy were delivered that resulted in IC damage.  
A. PD treatments 
Fig. 7 shows example images from a pallidotomy in a PD 
patient. As was the case in ET patients, the IC was visible in 
axial imaging. Axial imaging also revealed the GPi as a 
hypointense area next to the IC. Coronal phase imaging allowed 
for visualization of the IC medial to the sonication target. A 
hyperintense area was also observed ventral to the sonicated 
target with a location consistent with the optic tract. This 
structure was also evident in sagittal imaging (Fig. S2). Imaging 
from the three additional pallidotomies are included in the 
Supplemental Data.   
IV. DISCUSSION 
Anatomic structures in the filtered phase maps were 
consistently visualized with high image contrast. These maps 
were created using the same imaging data used to generate the 
MRTI. While they had a low spatial resolution, they were 
automatically registered to the MRTI and included any image 
distortion that may have occurred when changing the imaging 
orientation and frequency-encoding direction (supplemental 
video 1). This distortion can be a millimeter or more with the 
low-bandwidth, single-echo MRTI sequence. Furthermore, the 
phase maps require no extra time to acquire. Such maps could 
also be acquired separately from the sonication at higher 
resolution if necessary. 
The IC was clearly visualized in every patient in the filtered 
phase maps. Protecting the IC is critical during MRgFUS 
thalamotomy and pallidotomy to avoid hemiparesis or other 
side effects [2]. Risk to the IC is exacerbated by the obliquity 
of the heating that is often observed [8], the proximity of the 
VIM and GPi to this tract, and the lower blood flow in dense 
white matter fiber tracts which may retard heat dissipation.  
In an earlier study in rabbits [23], we showed that one can 
use MRTI acquired during low-energy sonication to accurately 
predict the thermal dose at subsequent high-energy exposures. 
Using this approach along with visualization of the IC could 
prove useful to avoid damage (Fig. 6). Cognizant of the 
proximity to the IC, one could logically reposition the target 
more medially and/or dorsally in such cases. It might also be 
possible to use the accumulated thermal dose of multiple low-
energy sonications [25] at different closely-spaced locations to 
avoid damage while still achieving a thermally-ablated lesion 
with a sufficient volume. 
Along with safety concerns, the anatomic information in the 
phase maps might be useful to refine atlas-based targeting. The 
MRTI was centered on the target selected by the neurosurgeon. 
This target was determined based on anatomic measurements 
and adjusted based on symptom improvement, which was 
achieved in every patient. The agreement in the alignment of 
the target anteroposteriorly with the RN and the proximity of 
the lesion boundary to the IC laterally and the STN ventrally in 
both stereotactic atlases [1] and in the phase mapping suggest 
that these structures could also be used as landmarks to refine 
the standard targeting used by most neurosurgeons. Future 
investigation with imaging that can directly visualize the VIM 
[26, 27] or that visualize relevant white matter tracts with 
diffusion tensor imaging [28, 29] might be illuminating in 
understanding how direct targeting approaches compares to 
atlas-based targeting refined by anatomic landmarks visualized 
in the phase maps. While such direct targeting approaches are 
likely the gold standard in targeting for thalamotomy, they 
require non-standard imaging approaches, long scan times, and 
advanced image processing methods to visualize the VIM that 
may not be available to all sites. Furthermore, the need to 
acquire a pre-treatment MRI is an added expense.  
In PD patients, the ability to visualize the optic tract ventral 
to the sonication target in addition to the IC should also be 
useful for avoiding side effects. It also appears that the phase 
imaging can delineate the GPi, presumably due it its high iron 
content [30]. However, only four patients were examined, and 
additional work is needed to verify the consistency of the phase 
imaging to guide pallidotomy.  
It is unfortunate that a gap was consistently apparent in the 
coronal phase maps in lateroventral regions of the IC in many 
ET patients, as this area is at risk for off-target damage when 
the focal area is oblique. The reason for this gap is unclear, but 
it could be related to the angle of the white matter tracts fibers 
with respect to the magnetic field in those regions. The MRI 
magnitude and phase in organized tissue structures such as 
white matter tracts are orientation-dependent due to dipolar 
interactions between bound water protons. This effect has a null 
 
Fig. 7 Phase maps and corresponding T2-weighted images from a
pallidotomy in a patient with Parkinson’s disease. The IC was visible in 
the phase maps in both orientations. The GPi appeared hypointense in
axial phase images, but was not as readily discerned in the coronal
images. The optic tract was observed ventral to the GPi target in
coronal imaging. 
McDannold et al.: Using phase data from MR temperature imaging to visualize anatomy during MRI-guided focused ultrasound neurosurgery  
value when the structure is at the “magic angle” of 54.74° with 
respect to the magnetic field [4], which is consistent with our 
observations. The location of the IC in this gap could be inferred 
by extrapolation, but its precise boundary was less clear than in 
other areas. 
Another limitation of this study is that the MRTI was not 
aligned with the ACPC plane, but rather varied slightly between 
subjects. If this variability makes image interpretation 
challenging, one could separately acquire images aligned with 
the patient instead of the scanner. Also, the phase changes 
induced by heating often overlapped with the anatomic 
information. In some patients, this phase was sufficient to 
obscure the STN and IC in coronal imaging. This issue could 
be avoided by acquiring the images separately without 
sonication. It may be possible to use the temperature estimates 
to remove the heating-induced phase changes from the 
anatomic visualization. 
A. Conclusions 
The image data used to create MRTI during MRgFUS 
thermal ablation contains anatomic information that is relevant 
for refining lesion placement in atlas-based targeting of the 
VIM and preventing unwanted damage to the IC. This anatomic 
information is automatically registered to the thermal mapping, 
does not suffer from uncertainty due image distortion, and 
requires no extra time to acquire. This approach could be useful 
in improving efficacy, safety and treatment time during this 
noninvasive neurosurgical procedure. 
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Fig. S1 Angulation of the planes used for MRTI and phase mapping with respect to the ACPC plane. The MRTI was aligned with the MRI scanner, so its 
orientation varied between patients depending on the placement of the stereotactic frame. To visualize the tilt angle, the angulation of the planes used for 
coronal and axial MRTI in the 68 ET treatments are superimposed on the FIESTA treatment planning images from one patient. The AC and PC, the ACPC 
plane, and the plane perpendicular to the ACPC plane at 25% of the ACPC distance are also shown. 
 
 
 
  
Fig. S2 Sagittal examples for a thalamotomy in an ET patient (top) and pallidotomy in a patient with PD (bottom). In ET patients, the STN was hypointense 
and appeared directly below the heated region in the phase mapping. In PD patients, the optic tract was directly below the heated region and was 
hyperintense. T1-weighted MRI acquired at 24 h after FUS are shown. In the PD patient, the FGATIR sequence was used (Sudhyadhom et al., Neuroimage, 
7; T44-T52, 2009).  
  
TABLE I 
PATIENT AND TREATMENT INFORMATION 
Patient Age # soni-cations 
Multi-echo 
MRTI 
ACPC dis-
tance (mm) 
Midline to target 
(mm) 
Ventricle to 
target (mm) 
PC to target 
(%ACPC dist.) 
PC to target 
(mm) 
ACPC plane to tar-
get (mm) 
ET 1 58M 15 N 24.7 11.4 14.0 24.2 6.0 -1.0 
ET 2 65F 20 N 24.8 11.0 14.0 22.1 5.5 0.3 
ET 3 78M 17 N 27.5 11.7 15.3 27.0 7.4 -0.2 
ET 4 72F 15 N 25.0 10.8 13.9 24.6 6.2 0.1 
ET 5 65M 13 N 26.4 11.4 14.9 25.5 6.7 0.4 
ET 6 69M 28 N 27.4 11.9 15.8 20.4 5.6 -0.3 
ET 7 68M 15 N 28.2 10.8 14.8 19.6 5.5 0.7 
ET 8 77F 17 N 24.9 10.8 13.8 22.8 5.7 0.1 
ET 9 83F 12 N 24.1 10.6 14.3 24.5 5.9 0.3 
ET 10 80M 12 N 29.2 10.1 16.5 23.3 6.8 -1.1 
ET 11 70M 9 N 28.2 9.5 14.8 22.7 6.4 -0.1 
ET 12 80F 12 N 23.5 10.9 15.1 25.1 5.9 0.3 
ET 13 91M 10 N 26.8 9.9 16.0 21.5 5.8 0.3 
ET 14 71M 13 Y 27.7 9.9 13.9 22.9 6.3 1.0 
ET 15 75M 12 Y 26.4 10.7 14.0 23.8 6.3 1.6 
ET 16 78M 20 Y 27.6 9.6 14.3 23.9 6.6 1.2 
ET 17 79F 12 Y 25.4 10.4 13.8 26.2 6.6 1.1 
ET 18 71M 16 Y 26.3 12.4 15.2 27.3 7.2 1.0 
ET 19 69F 13 Y 23.3 11.2 13.8 23.2 5.4 1.3 
ET 20 84M 10 Y 26.3 11.7 17.0 26.5 7.0 1.3 
ET 21 77M 10 Y 25.8 11.4 13.5 23.6 6.1 1.7 
ET 22 86F 10 Y 25.4 11.0 14.2 25.1 6.4 1.8 
ET 23 72M 12 Y 23.7 10.5 13.7 23.1 5.5 1.6 
ET 24 84M 13 Y 27.3 10.6 15.2 25.4 6.9 1.0 
ET 25 72F 11 Y 24.9 10.2 14.5 24.4 6.1 1.0 
ET 26 81M 13 Y 26.5 10.6 15.5 25.1 6.7 0.2 
ET 27 79M 12 Y 28.4 11.9 15.4 26.2 7.5 1.9 
ET 28 83M 12 Y 30.1 10.2 16.1 23.4 7.1 1.0 
ET 29 73M 11 Y 27.0 10.8 14.2 25.4 6.9 0.4 
ET 30 67F 9 Y 24.0 11.6 13.5 25.6 6.2 2.2 
ET 31 85F 16 Y 26.1 10.6 13.6 20.2 5.3 1.7 
ET 32 72M 14 Y 26.8 11.3 14.8 28.4 7.6 -0.1 
ET 33 68M 10 Y 25.7 10.7 14.6 26.0 6.7 0.6 
ET 34 81M 8 Y 28.7 8.9 13.9 24.0 6.9 1.9 
ET 35 72F 10 Y 27.0 10.5 16.6 25.3 6.8 1.5 
ET 36 67M 15 Y 26.9 10.4 14.6 25.5 6.9 1.0 
ET 37 74M 11 Y 26.6 9.7 14.7 23.4 6.2 0.8 
ET 38 76F 5 Y 22.9 9.4 13.1 23.3 5.3 1.6 
ET 39 66M 12 Y 25.0 11.8 14.2 30.4 7.6 1.4 
ET 40 75M 8 Y 27.7 10.2 15.1 25.4 7.0 1.6 
 
  
TABLE SI (CONTINUED) 
PATIENT AND TREATMENT INFORMATION 
Patient Age # soni-cations 
Multi-echo 
MRTI 
ACPC dis-
tance (mm) 
Midline to target 
(mm) 
Ventricle to 
target (mm) 
PC to target 
(%ACPC dist.) 
PC to target 
(mm) 
ACPC plane to tar-
get (mm) 
ET 41 60F 10 Y 26.1 10.9 14.0 23.4 6.1 1.8 
ET 42 78M 17 Y 25.6 9.3 14.0 23.9 6.1 1.7 
ET 43 72M 12 Y 24.0 11.1 15.7 27.2 6.5 0.4 
ET 44 68F 7 Y 26.1 10.0 13.6 25.6 6.7 0.7 
ET 45 73F 8 Y 23.7 11.6 14.1 26.2 6.2 -0.4 
ET 46 89F 10 Y 24.1 8.8 14.4 25.5 6.2 0.6 
ET 47 70F 12 Y 25.8 10.6 13.3 25.5 6.6 1.7 
ET 48 68F 10 Y 25.9 10.7 14.4 28.0 7.2 2.1 
ET 49 75F 10 Y 27.8 9.5 14.7 30.6 8.5 1.8 
ET 50 84M 12 Y 27.1 8.9 13.5 24.2 6.6 2.2 
ET 51 73F 12 Y 26.1 11.1 14.1 31.5 8.2 2.5 
ET 52 73F 12 Y 25.9 6.7 12.5 32.3 8.4 0.0 
ET 53 76M 12 Y 26.7 8.2 11.5 32.2 8.6 1.1 
ET 54 68M 11 N 26.6 10.3 16.2 27.2 7.2 1.4 
ET 55 79M 12 Y 28.2 9.7 14.7 26.1 7.4 2.8 
ET 56 79F 11 Y 27.1 10.0 15.2 23.7 6.4 1.2 
ET 57 66F 7 Y 24.6 10.7 14.0 27.4 6.7 1.0 
ET 58 65M 10 Y 29.8 10.9 14.7 25.4 7.6 1.7 
ET 59 87M 8 Y 25.0 9.2 14.0 25.1 6.3 2.2 
ET 60 83M 6 Y 29.1 9.9 14.1 27.5 8.0 2.0 
ET 61 92F 15 Y 27.7 9.9 15.0 26.4 7.3 1.9 
ET 62 87M 8 Y 26.6 9.9 15.8 27.7 7.4 1.9 
ET 63 74M 12 Y 26.2 10.5 14.9 23.9 6.3 1.7 
ET 64 73M 8 Y 26.8 11.0 13.2 27.0 7.2 0.9 
ET 65 79F 10 Y 26.5 10.4 14.4 25.5 6.8 1.1 
ET 66 89F 8 Y 26.8 9.9 15.4 23.1 6.2 0.9 
ET 67 89M 9 Y 27.3 9.8 14.2 24.3 6.6 1.4 
ET 68 69M 9 Y 27.2 10.2 13.9 25.3 6.9 1.9 
PD 1 73M 24 N 26.1      
PD 2 48M 13 N 26.2      
PD 3 41F 10 N 25.2      
PD 4 61F 7 Y 25.4      
 
 
ET 01 >
ET Patients 1-36
 Axial T2WI; 24h after MRgFUS
ET 02 > ET 03 > ET 04 > ET 05 > ET 06 > ET 07 ^ ET 08 ^ ET 09 ^
ET 10 > ET 11 ^ ET 12 > ET 13 ^ ET 14 > ET 15 ^ ET 16 > ET 17 > ET 18 >
ET 19 > ET 20 > ET 21 > ET 22 ^ ET 23 > ET 24 > ET 25 > ET 26 ^ ET 27 >
ET 28 > ET 29 > ET 30 ^ ET 31 > ET 32 > ET 33 > ET 34 > ET 35 > ET 36 ^
RN IC dose (AP) dose (LR) 25% ACPC dist. AC, PC
ET 01 >
ET Patients 1-36
 Axial T2WI; 24h after MRgFUS
ET 02 > ET 03 > ET 04 > ET 05 > ET 06 > ET 07 ^ ET 08 ^ ET 09 ^
ET 10 > ET 11 ^ ET 12 > ET 13 ^ ET 14 > ET 15 ^ ET 16 > ET 17 > ET 18 >
ET 19 > ET 20 > ET 21 > ET 22 ^ ET 23 > ET 24 > ET 25 > ET 26 ^ ET 27 >
ET 28 > ET 29 > ET 30 ^ ET 31 > ET 32 > ET 33 > ET 34 > ET 35 > ET 36 ^
RN IC dose (AP) dose (LR) 25% ACPC dist. AC, PC
ET 01 >
ET Patients 1-36
 Axial T2WI; 24h after MRgFUS
ET 02 > ET 03 > ET 04 > ET 05 > ET 06 > ET 07 ^ ET 08 ^ ET 09 ^
ET 10 > ET 11 ^ ET 12 > ET 13 ^ ET 14 > ET 15 ^ ET 16 > ET 17 > ET 18 >
ET 19 > ET 20 > ET 21 > ET 22 ^ ET 23 > ET 24 > ET 25 > ET 26 ^ ET 27 >
ET 28 > ET 29 > ET 30 ^ ET 31 > ET 32 > ET 33 > ET 34 > ET 35 > ET 36 ^
RN IC dose (AP) dose (LR) 25% ACPC dist. AC, PC
ET 01 >
ET Patients 1-36
 Axial T2WI; 24h after MRgFUS
ET 02 > ET 03 > ET 04 > ET 05 > ET 06 > ET 07 ^ ET 08 ^ ET 09 ^
ET 10 > ET 11 ^ ET 12 > ET 13 ^ ET 14 > ET 15 ^ ET 16 > ET 17 > ET 18 >
ET 19 > ET 20 > ET 21 > ET 22 ^ ET 23 > ET 24 > ET 25 > ET 26 ^ ET 27 >
ET 28 > ET 29 > ET 30 ^ ET 31 > ET 32 > ET 33 > ET 34 > ET 35 > ET 36 ^
RN IC dose (AP) dose (LR) 25% ACPC dist. AC, PC
ET 37 >
ET Patients 37-68
Axial T2WI; 24h after MRgFUS
ET 38 ^ ET 39 > ET 40 > ET 41 > ET 42 > ET 43 ^ ET 44 > ET 45 >
ET 46 > ET 47 > ET 48 ^ ET 49 > ET 50 > ET 51 > ET 52 > ET 53 > ET 54 ^
ET 55 > ET 56 > ET 57 > ET 58 > ET 59 > ET 60 > ET 61 > ET 62 > ET 63 >
ET 64 > ET 65 ^ ET 66 > ET 67 ^ ET 68 >
RN IC dose (AP) dose (LR) 25% ACPC dist. AC, PC
ET 37 >
ET Patients 37-68
Axial T2WI; 24h after MRgFUS
ET 38 ^ ET 39 > ET 40 > ET 41 > ET 42 > ET 43 ^ ET 44 > ET 45 >
ET 46 > ET 47 > ET 48 ^ ET 49 > ET 50 > ET 51 > ET 52 > ET 53 > ET 54 ^
ET 55 > ET 56 > ET 57 > ET 58 > ET 59 > ET 60 > ET 61 > ET 62 > ET 63 >
ET 64 > ET 65 ^ ET 66 > ET 67 ^ ET 68 >
RN IC dose (AP) dose (LR) 25% ACPC dist. AC, PC
ET 37 >
ET Patients 37-68
Axial T2WI; 24h after MRgFUS
ET 38 ^ ET 39 > ET 40 > ET 41 > ET 42 > ET 43 ^ ET 44 > ET 45 >
ET 46 > ET 47 > ET 48 ^ ET 49 > ET 50 > ET 51 > ET 52 > ET 53 > ET 54 ^
ET 55 > ET 56 > ET 57 > ET 58 > ET 59 > ET 60 > ET 61 > ET 62 > ET 63 >
ET 64 > ET 65 ^ ET 66 > ET 67 ^ ET 68 >
RN IC dose (AP) dose (LR) 25% ACPC dist. AC, PC
ET 37 >
ET Patients 37-68
Axial T2WI; 24h after MRgFUS
ET 38 ^ ET 39 > ET 40 > ET 41 > ET 42 > ET 43 ^ ET 44 > ET 45 >
ET 46 > ET 47 > ET 48 ^ ET 49 > ET 50 > ET 51 > ET 52 > ET 53 > ET 54 ^
ET 55 > ET 56 > ET 57 > ET 58 > ET 59 > ET 60 > ET 61 > ET 62 > ET 63 >
ET 64 > ET 65 ^ ET 66 > ET 67 ^ ET 68 >
RN IC dose (AP) dose (LR) 25% ACPC dist. AC, PC
ET 01 >
ET Patients 1-36 
Coronal T2WI; 24h after MRgFUS
ET 02 > ET 03 > ET 04 ^ ET 05 > ET 06 ^ ET 07 > ET 08 > ET 09 ^
ET 10 > ET 11 ^ ET 12 > ET 13 > ET 14 > ET 15 > ET 16 > ET 17 > ET 18 ^
ET 19 ^ ET 20 ^ ET 21 ^ ET 22 > ET 23 ^ ET 24 > ET 25 > ET 26 > ET 27 ^
ET 28 > ET 29 > ET 30 ^ ET 31 > ET 32 > ET 33 > ET 34 ^ ET 35 ^ ET 36 >
RN IC dose(SI) dose (LR) STN ACPC plane
ET 01 >
ET Patients 1-36 
Coronal T2WI; 24h after MRgFUS
ET 02 > ET 03 > ET 04 ^ ET 05 > ET 06 ^ ET 07 > ET 08 > ET 09 ^
ET 10 > ET 11 ^ ET 12 > ET 13 > ET 14 > ET 15 > ET 16 > ET 17 > ET 18 ^
ET 19 ^ ET 20 ^ ET 21 ^ ET 22 > ET 23 ^ ET 24 > ET 25 > ET 26 > ET 27 ^
ET 28 > ET 29 > ET 30 ^ ET 31 > ET 32 > ET 33 > ET 34 ^ ET 35 ^ ET 36 >
RN IC dose(SI) dose (LR) STN ACPC plane
ET 01 >
ET Patients 1-36 
Coronal T2WI; 24h after MRgFUS
ET 02 > ET 03 > ET 04 ^ ET 05 > ET 06 ^ ET 07 > ET 09 ^
ET 10 > ET 11 ^ ET 12 > ET 13 > ET 14 > ET 15 > ET 16 > ET 17 > ET 18 ^
ET 19 ^ ET 20 ^ ET 21 ^ ET 22 > ET 23 ^ ET 24 > ET 25 > ET 26 > ET 27 ^
ET 28 > ET 29 > ET 30 ^ ET 31 > ET 32 > ET 33 > ET 34 ^ ET 35 ^ ET 36 >
RN IC dose(SI) dose (LR) STN ACPC plane
ET 01 >
ET Patients 1-36 
Coronal T2WI; 24h after MRgFUS
ET 02 > ET 03 > ET 04 ^ ET 05 > ET 06 ^ ET 07 > ET 09 ^
ET 10 > ET 11 ^ ET 12 > ET 13 > ET 14 > ET 15 > ET 16 > ET 17 > ET 18 ^
ET 19 ^ ET 20 ^ ET 21 ^ ET 22 > ET 23 ^ ET 24 > ET 25 > ET 26 > ET 27 ^
ET 28 > ET 29 > ET 30 ^ ET 31 > ET 32 > ET 33 > ET 34 ^ ET 35 ^ ET 36 >
RN IC dose(SI) dose (LR) STN ACPC plane
ET 37 >
ET Patients 37-68
Coronal T2WI; 24h after MRgFUS
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